Metastatic Basal cell carcinoma

DrugDrug NameDrug Description
DB08828VismodegibVismodegib inhibits the hedgehog signalling pathway and is indicated for treatment of adult basal cell carcinoma. FDA approved on Jan 30, 2012.
DrugDrug NamePhaseStatusCount
DB14681Cortisone1Recruiting1
DB06186Ipilimumab1Recruiting1
DB09035Nivolumab1Recruiting1
DB00635Prednisone1Recruiting1
DB14646Prednisone acetate1Recruiting1
DB00864Tacrolimus1Recruiting1
DB08828Vismodegib4Recruiting1